Risperidone and Suicidality in Major Depressive Disorder
Status:
Completed
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to investigate the efficacy of risperidone as an adjunct to an
antidepressant treatment in the acute management of suicidality during an episode of major
depressive disorder.